Byron Nash Renal Medullary Carcinoma Awareness Act of 2023
The summary
What this bill does
Byron Nash Renal Medullary Carcinoma Awareness Act of 2023 [sic]
This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)
Legislative timeline
From introduction
Jan 3, 2025
Introduced & referred to committee
Congressional support
Sponsors & Cosponsors
U.S. Representative - TX District 9 · D-TX
Roll-call vote
The vote, by member
The vote, by member
VERSION CHANGES
What changed,
and where.
Loading the bill text comparison.
Bill Metadata
| Congress | 119 |
| Bill Type | HR |
| Bill Number | 124 |
| Origin Chamber | House |
| Current Status | Referred to the House Committee on Energy and Commerce. |
| Policy Area | Health |
| Primary Committee | Not assigned |
| Introduced | January 3, 2025 |
| Latest Action | January 3, 2025 |
| Cosponsors | 0 · House vote — · 1 views |